| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ibudilast | 50847-11-5 | sc-203080 | 10 mg | $218.00 | 1 | |
Ibudilast functions as a selective phosphodiesterase 1A (PDE1A) inhibitor, distinguished by its ability to engage in specific electrostatic interactions with the enzyme's active site. This compound demonstrates unique conformational flexibility, allowing it to stabilize transient enzyme-substrate complexes. Its kinetic profile reveals a non-competitive inhibition mechanism, which alters the enzyme's turnover rate and impacts calcium signaling pathways, showcasing its intricate role in cellular regulation. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine is a selective inhibitor of PDE1A. It binds to the catalytic site, reducing the enzyme's ability to hydrolyze cGMP and cAMP. | ||||||
8-Methoxymethyl-IBMX | 78033-08-6 | sc-201192 sc-201192A | 10 mg 50 mg | $354.00 $1173.00 | 2 | |
8-MM-IBMX acts as a non-selective inhibitor of PDE1A. It competitively inhibits the enzyme by mimicking the structure of cGMP. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine is a dual PDE3/PDE4 inhibitor that also shows inhibitory activity against PDE1A, blocking the enzyme's action on cAMP and cGMP. | ||||||
MY-5445 | 78351-75-4 | sc-201195 | 10 mg | $153.00 | 2 | |
MY-5445 is a selective PDE1A inhibitor, effectively blocking the enzyme′s catalytic activity towards cGMP and cAMP. | ||||||
8-Bromoguanosine 3′, 5′ -cyclic monophosphoric acid | 31356-94-2 | sc-291685 sc-291685A | 5 mg 10 mg | $116.00 $206.00 | ||
8-Br-cGMP inhibits PDE1A by mimicking cGMP's structure, competitively binding to the active site and reducing enzyme activity. | ||||||
Anagrelide hydrochloride | 58579-51-4 | sc-203513 sc-203513A | 10 mg 50 mg | $103.00 $587.00 | 1 | |
Anagrelide, a PDE3 inhibitor, also exhibits inhibitory activity against PDE1A, interfering with the hydrolysis of cAMP and cGMP. | ||||||
EHNA hydrochloride | 51350-19-7 | sc-201184 sc-201184A | 10 mg 50 mg | $104.00 $379.00 | 6 | |
EHNA hydrochloride inhibits PDE1A by competing with cAMP, thereby reducing the enzyme′s activity in hydrolyzing cAMP and cGMP. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of PDE1A, reducing the hydrolysis of cAMP and cGMP by competitively binding to the active site. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone, primarily a PDE3 inhibitor, also exhibits some inhibitory activity towards PDE1A, particularly affecting cAMP hydrolysis. | ||||||